Clinical trial
Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in…
NCT00206414 · Baylor Breast Care Center, Other · Terminated
Key facts
| NCT number | NCT00206414 |
|---|---|
| Title | Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer |
| Official title | Arimidex/Faslodex/Iressa Study: A Phase II Trial of Primary Systemic Therapy Using a Combination of Arimidex, Faslodex and Iressa (Gefitinib) in Postmenopausal Women With Hormone Receptor Positive Breast Cancer |
| Lead sponsor | Baylor Breast Care Center, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | BREAST CANCER |
| Intervention type | Drug |
| Interventions | Iressa Day 1 given with Arimidex and Faslodex, Iressa Day 21 given with Arimidex and Faslodex |
| Enrollment | 15 |
| Start date | Jan 1, 2003 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Feb 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: